Integra Lifesciences Holdings Corp Hits New 1-Year High at $51.24 (IART)
Shares of Integra Lifesciences Holdings Corp (NASDAQ:IART) reached a new 52-week high on Friday , Analyst Ratings.Net reports. The company traded as high as $51.24 and last traded at $50.77, with a volume of 179,314 shares trading hands. The stock had previously closed at $49.67.
A number of analysts have recently weighed in on IART shares. Analysts at Oppenheimer reiterated an “outperform” rating on shares of Integra Lifesciences Holdings Corp in a research note on Wednesday, August 6th. They now have a $57.00 price target on the stock, up previously from $55.00. Analysts at Jefferies Group raised their price target on shares of Integra Lifesciences Holdings Corp from $54.00 to $57.00 in a research note on Wednesday, August 6th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Integra Lifesciences Holdings Corp presently has an average rating of “Hold” and an average target price of $52.57.
The stock’s 50-day moving average is $47.82 and its 200-day moving average is $46.50. The company’s market cap is $1.662 billion.
Integra Lifesciences Holdings Corp (NASDAQ:IART) last announced its earnings results on Tuesday, August 5th. The company reported $0.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.64 by $0.04. The company had revenue of $231.40 million for the quarter, compared to the consensus estimate of $229.32 million. During the same quarter in the previous year, the company posted $0.60 earnings per share. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. Analysts expect that Integra Lifesciences Holdings Corp will post $2.94 EPS for the current fiscal year.
In other Integra Lifesciences Holdings Corp news, VP Brian Larkin unloaded 1,947 shares of the stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $48.28, for a total value of $94,001.16. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) is an integrated medical technology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.